Regression of liver metastases of occult carcinoid tumor with slow release Lanreotide therapy

doi:10.3748/wjg.v11.i13.2041

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3603)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

343

HTML

2819

Figures (1-3)

234

Tables (1-1)

207

Sum=3603

Apr 7, 2005 (publication date) through Dec 20, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Apr 7, 2005; 11(13): 2041-2044
Published online Apr 7, 2005. doi: 10.3748/wjg.v11.i13.2041

Full Size Figure Download Figure

Figure 2 Most metastatic tumor cells in the liver demonstrate immunoreactivity for STTR1 (A), STTR2 (B), STTR3 (C), and STTR5 (D) on the cell membrane (×200).

Citation: Bondanelli M, Ambrosio MR, Zatelli MC, Cavazzini L, Al Jandali Rifa’y L, degli Uberti EC. Regression of liver metastases of occult carcinoid tumor with slow release Lanreotide therapy. World J Gastroenterol 2005; 11(13): 2041-2044
URL: https://www.wjgnet.com/1007-9327/full/v11/i13/2041.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i13.2041